ClariVest Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $9.76M | Hold |
600,816
| – | – | 1% | 11 |
|
|
2024
Q2 | $9.76M | Buy |
600,816
+9,816
| +2% | +$160K | 1% | 11 |
|
|
2024
Q1 | $8.34M | Buy |
591,000
+198,700
| +51% | +$2.8M | 0.86% | 13 |
|
|
2023
Q4 | $4.1M | Sell |
392,300
-7,600
| -2% | -$79.3K | 0.23% | 78 |
|
|
2023
Q3 | $4.08M | Buy |
399,900
+1,400
| +0.4% | +$14.3K | 0.22% | 79 |
|
|
2023
Q2 | $3M | Sell |
398,500
-9,600
| -2% | -$72.3K | 0.15% | 97 |
|
|
2023
Q1 | $3.61M | Sell |
408,100
-7,300
| -2% | -$64.6K | 0.16% | 114 |
|
|
2022
Q4 | $3.79M | Sell |
415,400
-16,100
| -4% | -$147K | 0.18% | 103 |
|
|
2022
Q3 | $3.48M | Buy |
431,500
+33,000
| +8% | +$266K | 0.17% | 108 |
|
|
2022
Q2 | $3M | Sell |
398,500
-12,100
| -3% | -$91K | 0.13% | 136 |
|
|
2022
Q1 | $3.86M | Buy |
410,600
+313,100
| +321% | +$2.94M | 0.15% | 138 |
|
|
2021
Q4 | $782K | Buy |
97,500
+9,100
| +10% | +$73K | 0.02% | 370 |
|
|
2021
Q3 | $861K | Buy |
88,400
+1,000
| +1% | +$9.74K | 0.03% | 344 |
|
|
2021
Q2 | $865K | Sell |
87,400
-4,600
| -5% | -$45.5K | 0.03% | 319 |
|
|
2021
Q1 | $1.06M | Sell |
92,000
-3,600
| -4% | -$41.6K | 0.04% | 278 |
|
|
2020
Q4 | $923K | Sell |
95,600
-300
| -0.3% | -$2.9K | 0.03% | 282 |
|
|
2020
Q3 | $864K | Buy |
95,900
+17,600
| +22% | +$159K | 0.03% | 315 |
|
|
2020
Q2 | $966K | Buy |
78,300
+26,350
| +51% | +$325K | 0.03% | 326 |
|
|
2020
Q1 | $467K | Buy |
+51,950
| New | +$467K | 0.01% | 405 |
|
|
2019
Q2 | – | Sell |
-9,818
| Closed | -$154K | – | 748 |
|
|
2019
Q1 | $154K | Sell |
9,818
-300
| -3% | -$4.71K | ﹤0.01% | 526 |
|
|
2018
Q4 | $156K | Sell |
10,118
-1,482
| -13% | -$22.9K | ﹤0.01% | 569 |
|
|
2018
Q3 | $251K | Buy |
+11,600
| New | +$251K | ﹤0.01% | 560 |
|